ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 33 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $606,911 | 0.0% | 443,001 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $606,911 | -41.9% | 443,001 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $1,045,482 | +1.7% | 443,001 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,027,762 | +326.5% | 443,001 | +407.5% | 0.00% | +100.0% |
| Q3 2022 | $241,000 | +28.2% | 87,286 | +13.2% | 0.00% | – |
| Q2 2022 | $188,000 | -38.2% | 77,100 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $304,000 | -10.6% | 77,100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $340,000 | +655.6% | 77,100 | +966.7% | 0.00% | – |
| Q3 2021 | $45,000 | -84.3% | 7,228 | -80.0% | 0.00% | -100.0% |
| Q2 2021 | $286,000 | -25.9% | 36,111 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $386,000 | -30.6% | 36,111 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $556,000 | – | 36,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 245,000 | $676,000 | 0.76% |
| BVF INC/IL | 2,326,710 | $6,422,000 | 0.26% |
| Cormorant Asset Management, LP | 1,223,500 | $3,377,000 | 0.24% |
| Ikarian Capital, LLC | 221,830 | $612,000 | 0.12% |
| JMAC ENTERPRISES LLC | 54,538 | $151,000 | 0.04% |
| Woodline Partners LP | 516,675 | $1,426,000 | 0.02% |
| Eversept Partners, LP | 67,743 | $186,971 | 0.02% |
| INGALLS & SNYDER LLC | 51,149 | $141,000 | 0.01% |
| Point72 Asset Management, L.P. | 375,000 | $1,035,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,050 | $61,000 | 0.00% |